Wedbush Comments on AnaptysBio’s Q4 Earnings (NASDAQ:ANAB)

AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) – Investment analysts at Wedbush issued their Q4 2026 earnings per share estimates for shares of AnaptysBio in a report issued on Thursday, August 7th. Wedbush analyst D. Nierengarten forecasts that the biotechnolo…

Read Full Article →